Differential roles of Fas ligand in spontaneous and actively induced autoimmune encephalomyelitis

Clinical Immunology

Volumn 95, Issue 3, 2000, Pages 203-211

  Liu, Tzu Shang T ^a   Hilliard, Brendan ^a   Samoilova, Elena B ^a   Chen, Youhai ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Apoptosis; Autoimmunity; Brain; EAE MS; Fas (CD95)

Indexed keywords

CYTOKINE; FAS ANTIGEN; FAS LIGAND; MYELIN BASIC PROTEIN; PERTUSSIS TOXIN; T LYMPHOCYTE RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNITY; BRAIN; ENCEPHALOMYELITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE MUTATION; MALE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0034128599     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2000.4861     Document Type: Article

References (36)

1. Nagata S., Golstein P. The Fas death factor. Science. 267:1995;1449.
2. Suda T., Okazaki T., Naito Y., Yokota T., Arai N., Ozaki S., Nakao K., Nagata S. Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 154:1995;3806.
3. Dowling P., Shang G., Raval S., Menonna J., Cook S., Husar W. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J. Exp. Med. 184:1996;1513.
4. Vergelli M., Hemmer B., Muraro P. A., Tranquill L., Biddison W. E., Sarin A., McFarland H. F., Martin R. Human autoreactive CD4+ T cell clones use perforin- or Fas/Fas ligand-mediated pathways for target cell lysis. J. Immunol. 158:1997;2756.
5. Firestein G. S., Yeo M., Zvaifler N. J. Apoptosis in rheumatoid arthitis synovium. J. Clin. Invest. 96:1995;1631.
6. Rensing-Ehl A., Hess S., Ziegler-Heitbrock H. W., Riethmuller G., Engelmann H. Fas/Apo-1 activates nuclear factor kappa B and induces interleukin-6 production. J. Inflammation. 45:1995;161.
7. Abreu-Martin M. T., Vidrich A., Lynch D. H., Targan S. R. Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-alpha and ligation of Fas antigen. J. Immunol. 155:1995;4147.
8. Ponton A., Clement M. V., Stamenkovic I. The CD95 (APO-1/Fas) receptor activates NF-kappaB independently of its cytotoxic function. J. Biol. Chem. 271:1996;8991.
9. Cohen P. L., Eisenberg R. A. The lpr and gld genes in systemic autoimmunity: Life and death in the Fas lane. Immunol. Today. 13:1992;427.
10. Cohen J. J., Duke R. C., Fadok V. A., Sellins K. S. Apoptosis and programmed cell death in immunity. Ann. Rev. Immunol. 10:1992;267.
11. Griffith T. S., Brunner T., Fletcher S. M., Green D. R., Ferguson T. A. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 270:1995;1189.
12. Zhang H., Yang Y., Horton J. L., Samoilova E. B., Judge T., Turka L. A., Wilson J. M., Chen Y. Amelioration of collagen-induced arthitis by Fas (CD95)-ligand gene transfer. J. Clin. Invest. 100:1997;1951.
13. Hahne M., Rimoldi D., Schoter M., Romero P., Scheier M., French L. E., Schneider P., Bornand T., Fontana A., Lienard D., Cerottini J., Tschopp J. Melanoma cell expression of Fas(Apo-1/CD95) ligand: Implications for tumor immune escape. Science. 274:1996;1363.
14. Giordano C., Stassi G., De Maria R., Todaro M., Richiusa P., Papoff G., Ruberti G., Bagnasco M., Testi R., Galluzzo A. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science. 275:1997;960.
15. Chervonsky A. V., Wang Y., Wong F. S., Visintin I., Flavell R. A., Janeway C. A. Jr., Matis L. A. The role of Fas in autoimmune diabetes. Cell. 89:1997;17.
16. D'Souza S. D., Bonetti B., Balasingam V., Cashman N. R., Barker P. A., Troutt A. B., Raine C. S., Antel J. P. Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J. Exp. Med. 184:1996;2361.
17. Bonetti B., Raine C. S. Multiple sclerosis: Oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann. Neurol. 42:1997;74.
18. Xerri L., Devilard E., Hassoun J., Mawas C., Birg F. Fas ligand is not only expressed in immune privileged human organs but is also coexpressed with Fas in various epithelial tissues. Mol. Pathol. 50:1997;87.
19. Waldner H., Sobel R. A., Howard E., Kuchroo V. K. Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. J. Immunol. 159:1997;3100.
20. Sabelko K. A., Kelly K. A., MNahm M. H., Cross A. H., Russell J. H. Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system. J. Immunol. 159:1997;3096.
21. Sabelko-Downes K. A., Cross A. H., Russell J. H. Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis. J. Exp. Med. 189:1999;1195.
22. Dittel B. N., Merchant R. M., Janeway C. A. Jr. Evidence for Fas-dependent and Fas-independent mechanisms in the pathogenesis of experimental autoimmune encephalomyelitis. J. Immunol. 162:1999;6392.
23. Lafaille J. J., Keere F. V., Hsu A. L., Baron J. L., Haas W., Raine C. S., Tonegawa S. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J. Exp. Med. 186:1997;307.
24. Lafaille J. J., Nagashima K., Katsuki M., Tonegawa S. High incidence of spontanous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell. 78:1994;399.
25. Chen Y., Kuchroo V. K., Inobe J.-I., Hafler D. A., Weiner H. L. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science. 265:1994;1237.
26. Moore G. R., Traugott U., Farooq M., Norton W. T., Raine C. S. Experimental autoimmune encephalomyelitis. Lab. Invest. 51:1984;416.
27. Goverman J., Woods A., Larson L., Weiner L. P., Hood L., Zaller D. M. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell. 72:1993;551.
28. Ben-Nun A., Yossefi S., Lehmann D. PPD and pertussis toxin as proteins active in protecting mice against experimental autoimmune encephalomyelitis. Eur. J. Immunol. 23:1993;689.
29. Khelef N., Zychlinsky A., Guiso N. Bordetella pertussis induces apoptosis in macrophages: Role of adenylate cyclase-hemolysin. Infect. Immun. 61:1993;4064.
30. Kang, S. M, Schneider, D. B, Lin, Z, Hanahan, D, Dichek, D. A, Stock, P. G, and, Baekkeskov, S, Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction, Nature Med. 3, 738, 1997.
31. Scott C. F. Jr., Tsurufuji M., Lu C. Y., Finberg R., Sy M. S. Comparison of antigen-specific T cell responses in autoimmune MRL/Mp-lpr/lpr and MRL/Mp-+/+ mice. J. Immunol. 132:1984;633.
32. Yui K., Bhandoola A., Radic M. Z., Komori S., Katsumata M., Greene M. I. Inhibition of abnormal T cell development and autoimmunity in gld mice by transgenic T cell receptor beta chain. Eur. J. Immunol. 22:1992;1693.
33. Chen Y., Hancock W. W., Marks R., Gonnella P., Weiner H. L. Mechanisms of recovery from experimental autoimmune encephalomyelitis: T cell deletion and immune deviation in myelin basic protein T cell receptor transgenic mice. J. Neuroimmunol. 82:1998;149.
34. Mercep M., Weissman A. M., Frank S. J., Klausner R. D., Ashwell J. D. Activation-driven programmed cell death and T cell receptor zeta eta expression. Science. 246:1989;1162.
35. Brunner T., Mogil R. J., LaFace D., Yoo N. J., Mahboubi A., Echeverri F., Martin S. J., Force W. R., Lynch D. H., Ware C. F., Green D. R. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature. 373:1995;441.
36. Mogil R. J., Radvanyi L., Gonzalez-Quintial R., Miller R., Mills G., Theofilopoulos A. N., Green D. R. Fas (CD95) participates in peripheral T cell deletion and associated apoptosis in vivo. Int. Immunol. 7:1995;1451.